Biblio
Export 1181 results:
Author Title Type [ Year] Filters: First Letter Of Last Name is D [Clear All Filters]
“Functional Neurophysiological Biomarkers of Early-Stage Alzheimer's Disease: A Perspective of Network Hyperexcitability in Disease Progression.”, J Alzheimers Dis, vol. 88, no. 3, pp. 809-836, 2022.
, “Glucometabolic Changes Are Associated with Structural Gray Matter Alterations in Prodromal Dementia.”, J Alzheimers Dis, vol. 89, no. 4, pp. 1293-1302, 2022.
, “High Soluble Amyloid-β42 Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer's Disease-Causing Mutations.”, J Alzheimers Dis, vol. 90, no. 1, pp. 333-348, 2022.
, “High Soluble Amyloid-β42 Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer's Disease-Causing Mutations.”, J Alzheimers Dis, vol. 90, no. 1, pp. 333-348, 2022.
, “HMGCS2-Induced Autophagic Degradation of Tau Involves Ketone Body and ANKRD24.”, J Alzheimers Dis, vol. 91, no. 1, pp. 407-426, 2022.
, “Impact of COVID-19 on 'Living Well' with Mild-to-Moderate Dementia in the Community: Findings from the IDEAL Cohort.”, J Alzheimers Dis, vol. 85, no. 2, pp. 925-940, 2022.
, “Impaired Experience-Dependent Refinement of Place Cells in a Rat Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1907-1916, 2022.
, “Improved Alzheimer's Disease versus Frontotemporal Lobar Degeneration Differential Diagnosis Combining EEG and Neurochemical Biomarkers: A Pilot Study.”, J Alzheimers Dis, vol. 90, no. 4, pp. 1739-1747, 2022.
, “Improved Alzheimer's Disease versus Frontotemporal Lobar Degeneration Differential Diagnosis Combining EEG and Neurochemical Biomarkers: A Pilot Study.”, J Alzheimers Dis, vol. 90, no. 4, pp. 1739-1747, 2022.
, “Incidence and Outcomes of SARS-CoV-2 Infection in Older Adults Living with Dementia: A Population-Based Cohort Study.”, J Alzheimers Dis, vol. 89, no. 2, pp. 681-693, 2022.
, “Insulin-Like Growth Factor, Inflammation, and MRI Markers of Alzheimer's Disease in Predominantly Middle-Aged Adults.”, J Alzheimers Dis, vol. 88, no. 1, pp. 311-32, 2022.
, “Integrating the Synergy of the Gut Microbiome into Regenerative Medicine: Relevance to Neurological Disorders.”, J Alzheimers Dis, vol. 87, no. 4, pp. 1451-1460, 2022.
, “Interaction Between Diet and Microbiota in the Pathophysiology of Alzheimer's Disease: Focus on Polyphenols and Dietary Fibers.”, J Alzheimers Dis, vol. 86, no. 3, pp. 961-982, 2022.
, “Investigating Causal Relations Between Circulating Metabolites and Alzheimer's Disease: A Mendelian Randomization Study.”, J Alzheimers Dis, vol. 87, no. 1, pp. 463-477, 2022.
, “Low-Dose Radiation Therapy Reduces Amyloid Load in Young 3xTg-AD Mice.”, J Alzheimers Dis, vol. 86, no. 2, pp. 641-653, 2022.
, “Mild Traumatic Brain Injury is Related to Elevated Cerebrospinal Fluid Tau in Alzheimer's Disease Dementia.”, J Alzheimers Dis, vol. 87, no. 4, pp. 1491-1496, 2022.
, “Non-Alcoholic Fatty Liver Disease, Liver Fibrosis, and Regional Amyloid-β and Tau Pathology in Middle-Aged Adults: The Framingham Study.”, J Alzheimers Dis, vol. 86, no. 3, pp. 1371-1383, 2022.
, “Non-Alcoholic Fatty Liver Disease, Liver Fibrosis, and Regional Amyloid-β and Tau Pathology in Middle-Aged Adults: The Framingham Study.”, J Alzheimers Dis, vol. 86, no. 3, pp. 1371-1383, 2022.
, “A Novel Panel of Plasma Proteins Predicts Progression in Prodromal Alzheimer's Disease.”, J Alzheimers Dis, vol. 88, no. 2, pp. 549-561, 2022.
, “Obesity-Associated Neurodegeneration Pattern Mimics Alzheimer's Disease in an Observational Cohort Study.”, J Alzheimers Dis, vol. 91, no. 3, pp. 1059-1071, 2022.
, “Obesity-Associated Neurodegeneration Pattern Mimics Alzheimer's Disease in an Observational Cohort Study.”, J Alzheimers Dis, vol. 91, no. 3, pp. 1059-1071, 2022.
, “The Outcome of Patients with Amyloid-Negative Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 86, no. 2, pp. 629-640, 2022.
, “Plasma Cholesterol Levels as Potential Nutritional Biomarkers for Lewy Body Dementia.”, J Alzheimers Dis, vol. 86, no. 2, pp. 779-786, 2022.
, “Plasma Myeloperoxidase as a Potential Biomarker of Patient Response to Anti-Dementia Treatment in Alzheimer's Disease.”, J Alzheimers Dis, vol. 89, no. 4, pp. 1483-1492, 2022.
, “Post-Stroke Cognitive Impairment: Epidemiology, Risk Factors, and Management.”, J Alzheimers Dis, vol. 86, no. 3, pp. 983-999, 2022.
,